• #1119644
  • 262
  • Glaxo Smith Kline #19515090652

Flulaval® Quadrivalent 2019 - 2020 Flu Vaccine 60 mcg / 0.5 mL Indicated For People 6 Months of Age and Above Prefilled Syringe 0.5 mL

FLULAVAL QUAD 2019, SYR 0.5ML (10DOSE/BX)

Features
  • FLULAVAL QUADRIVALENT is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
  • FLULAVAL QUADRIVALENT is approved for use in persons 6 months of age and older
  • FLULAVAL QUADRIVALENT has been standardized according to U.S. Public Health Service (USPHS) requirements for the 2019-2020 influenza season and is formulated to contain 60 micrograms (mcg) hemagglutinin (HA) per 0.5-mL dose in the recommended ratio of 15 mcg HA of each of the following 4 influenza virus strains (2 A strains and 2 B strains): A/Brisbane/02/2018 (H1N1) pdm09 (IVR-190), A/Kansas/14/2017 (H3N2) X-327, B/Maryland/15/2016 NYMC BX-69A (a B/Colorado/06/2017-like virus), and B/Phuket/3073/2013.
  • More …
  Log In to Order
or

Professionals Also Viewed


Product Specifications


McKesson #1119644
Manufacturer #19515090652
BrandFlulaval® Quadrivalent 2019 - 2020
ManufacturerGlaxo Smith Kline
Country of OriginUnknown
ApplicationFlu Vaccine
Container TypePrefilled Syringe
Dosage FormInjection
NDC Number19515090652
Storage RequirementsRequires Refrigeration
Strength60 mcg / 0.5 mL
TypeIntramuscular
UNSPSC Code51201608
UserIndicated For People 6 Months of Age and Above
Volume0.5 mL
Features
  • FLULAVAL QUADRIVALENT is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
  • FLULAVAL QUADRIVALENT is approved for use in persons 6 months of age and older
  • FLULAVAL QUADRIVALENT has been standardized according to U.S. Public Health Service (USPHS) requirements for the 2019-2020 influenza season and is formulated to contain 60 micrograms (mcg) hemagglutinin (HA) per 0.5-mL dose in the recommended ratio of 15 mcg HA of each of the following 4 influenza virus strains (2 A strains and 2 B strains): A/Brisbane/02/2018 (H1N1) pdm09 (IVR-190), A/Kansas/14/2017 (H3N2) X-327, B/Maryland/15/2016 NYMC BX-69A (a B/Colorado/06/2017-like virus), and B/Phuket/3073/2013.
  • The prefilled syringe is formulated without preservatives and does not contain thimerosal